VICTOR TREVINO

Dr. VICTOR TREVINO

Tecnológico de Monterrey, Escuela de Medicina
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
KYKosuke Yoshihara
Kosuke Yoshihara
MSMaria Shahmoradgoli
Maria Shahmoradgoli
EMEmmanuel Martínez
Emmanuel Martínez
RVRahulsimham Vegesna
Rahulsimham Vegesna
HKHoon Kim
Hoon Kim
RVRoel G.W. Verhaak
Roel G.W. Verhaak
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/.

25 December 2013 in Nature
Verified
Journal Article
Closed access
PDF file
AOAkinyemi I. Ojesina
Akinyemi I. Ojesina
LLLee Lichtenstein
Lee Lichtenstein
SFSamuel S. Freeman
Samuel S. Freeman
CPChandra Sekhar Pedamallu
Chandra Sekhar Pedamallu
IIIvan Imaz-Rosshandler
Ivan Imaz-Rosshandler
MMMatthew Meyerson
Matthew Meyerson

16 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RARaul Aguirre-Gamboa
Raul Aguirre-Gamboa
HGHugo Gomez-Rueda
Hugo Gomez-Rueda
EMEmmanuel Martínez-Ledesma
Emmanuel Martínez-Ledesma
AMAntonio Martínez-Torteya
Antonio Martínez-Torteya
RCRafael Chacolla-Huaringa
Rafael Chacolla-Huaringa
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for cancer prognosis. An important source of information for virtual validation is the high number of available cancer datasets. Nevertheless, assessing the prognostic performance of a gene expression signature along datasets is a difficult task for Biologists and Physicians and also time-consuming for Statisticians and Bioinformaticians. Therefore, to facilitate performance comparisons and validations of survival biomarkers for cancer outcomes, we developed SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets. The main input of SurvExpress is only the biomarker gene list. We generated a cancer database collecting more than 20,000 samples and 130 datasets with censored clinical information covering tumors over 20 tissues. We implemented a web interface to perform biomarker validation and comparisons in this database, where a multivariate survival analysis can be accomplished in about one minute. We show the utility and simplicity of SurvExpress in two biomarker applications for breast and lung cancer. Compared to other tools, SurvExpress is the largest, most versatile, and quickest free tool available. SurvExpress web can be accessed in http://bioinformatica.mty.itesm.mx/SurvExpress (a tutorial is included). The website was implemented in JSP, JavaScript, MySQL, and R.

1 September 2007 in Molecular Medicine
Verified
Journal Article
Open access
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
FFFrancesco Falciani
Francesco Falciani
HBHugo A. Barrera-Saldaña
Hugo A. Barrera-Saldaña
Among the many benefits of the Human Genome Project are new and powerful tools such as the genome-wide hybridization devices referred to as microarrays. Initially designed to measure gene transcriptional levels, microarray technologies are now used for comparing other genome features among individuals and their tissues and cells. Results provide valuable information on disease subcategories, disease prognosis, and treatment outcome. Likewise, they reveal differences in genetic makeup, regulatory mechanisms, and subtle variations and move us closer to the era of personalized medicine. To understand this powerful tool, its versatility, and how dramatically it is changing the molecular approach to biomedical and clinical research, this review describes the technology, its applications, a didactic step-by-step review of a typical microarray protocol, and a real experiment. Finally, it calls the attention of the medical community to the importance of integrating multidisciplinary teams to take advantage of this technology and its expanding applications that, in a slide, reveals our genetic inheritance and destiny.

1 July 2018 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
Mariel Araceli Oyervides-MuñozMariel Araceli Oyervides-Muñoz
Mariel Araceli Oyervides-Muñoz
Antonio Ali Perez-MayaAntonio Ali Perez-Maya
Antonio Ali Perez-Maya
HRHazyadee Frecia Rodríguez-Gutiérrez
Hazyadee Frecia Rodríguez-Gutiérrez
GGGabriela Sofía Gómez-Macias
Gabriela Sofía Gómez-Macias
OFOscar Raúl Fajardo-Ramírez
Oscar Raúl Fajardo-Ramírez
Maria Lourdes Garza-RodríguezMaria Lourdes Garza-Rodríguez
Maria Lourdes Garza-Rodríguez

1 March 2006 in Bioinformatics
Verified
Journal Article
Open access
PDF file
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
FFFrancesco Falciani
Francesco Falciani
Summary: The development of statistical models linking the molecular state of a cell to its physiology is one of the most important tasks in the analysis of Functional Genomics data. Because of the large number of variables measured a comprehensive evaluation of variable subsets cannot be performed with available computational resources. It follows that an efficient variable selection strategy is required. However, although software packages for performing univariate variable selection are available, a comprehensive software environment to develop and evaluate multivariate statistical models using a multivariate variable selection strategy is still needed. In order to address this issue, we developed GALGO, an R package based on a genetic algorithm variable selection strategy, primarily designed to develop statistical models from large-scale datasets. Availability: GALGO can be downloaded from Contact:vtrevino@itesm.mx; f.falciani@bham.ac.uk Supplementary information: Supplementary data are available at